Application of Lactobacillus plantarum CCFM1281 in alleviating sports fatigue
By using dairy products prepared by Lactobacillus plantarum CCFM1281 and other probiotics, combined with Lactobacillus German and Streptococcus thermophilus, the problem of major side effects of exercise fatigue treatment in the prior art has been solved, and the endurance and muscle damage to exercise are achieved. Significant improvements provide a highly targeted microbial solution.
Patent Information
- Application Number
- CN202211338232.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-10-28
- Publication Date
- 2024-11-01
- Estimated Expiration
- 2042-10-28
AI Technical Summary
The existing technology has exogenous drugs and dietary supplements that have great side effects in relieving exercise fatigue. They lack highly targeted microbial solutions and are difficult to effectively alleviate physical and mental fatigue during exercise through intestinal microbiota regulation.
Using Lactiplantibacillus plantarum CCFM1281, combined with Lactiplantibacillus Bulgarian subspecies JMCC0018 and Streptococcus thermophilus JMCC0019, a dairy product was prepared. The nutrient content and probiotic quantity of dairy products were increased through the fermentation process. Relieve exercise fatigue.
It significantly improves exercise endurance, reduces serum urea nitrogen and lactate dehydrogenase levels caused by exercise, increases muscle and muscle glycogen storage, maintains serum glucose levels, reduces exercise damage caused by high-intensity exercise, and comprehensively alleviates Exercise fatigue.
Smart Images

Figure CN116064313B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to application of Lactobacillus plantarum CCFM1281 in relieving sports fatigue, and belongs to the technical field of microorganisms. Background Art
[0002] Sports fatigue refers to the physiological phenomenon in which the maximum contraction force or maximum output power of muscles caused by exercise temporarily decreases. Since the physical manifestations of sports fatigue are less obvious, most people are unaware of the serious impact of sports fatigue. Most athletes and manual laborers suffer from it. Long-term fatigue will greatly affect their study, work and life. At present, the treatment of sports fatigue mostly adopts sleep and rest as the main method, supplemented by dietary medication. There are more products on the market for fatigue, such as drugs, functional drinks, meal replacement powders, etc., but these products will have some side effects to a greater or lesser extent, mainly exogenous counteracting the physical changes caused by fatigue, and there are certain risks and population targeting.
[0003] The human gastrointestinal tract contains many symbiotic bacteria, called microbiota, which benefit the host by digesting dietary components and eliminating pathogens. Probiotics are defined as "live microorganisms that confer a beneficial health effect on the host when ingested in adequate quantities." Lactobacillus plantarum is one of the probiotics, which has been shown to have certain health benefits such as immunomodulatory effects and inhibition of the growth of pathogenic bacteria.
[0004] With the continuous development of my country's sports industry and the progress of scientific research, it is crucial to relieve physical and mental fatigue during exercise through endogenous intestinal flora. As dairy products have become an indispensable food in people's daily lives, fermented dairy products are excellent carriers of probiotics. Finding probiotics that can relieve sports fatigue and applying them to fermented dairy products is of great significance to social groups who love sports.
[0005] In summary, it is necessary to find a strain of Lactobacillus plantarum that can relieve sports fatigue and apply it to the development of dairy products. Summary of the invention
[0006] The first object of the present invention is to provide Lactobacillus plantarum CCFM1281, which has been deposited in Guangdong Provincial Microbiological Culture Collection Center on September 15, 2022, with a deposit number of GDMCC No: 62797.
[0007] The second object of the present invention is to provide a composition containing the Lactobacillus plantarum CCFM1281.
[0008] In one embodiment, the number of Lactobacillus plantarum CCFM1281 is ≥ 1×109 CFU / mL or ≥1×10 9 CFU / g.
[0009] In one embodiment, the composition includes, but is not limited to, a microbial preparation, a functional food, or a dietary supplement.
[0010] In one embodiment, the composition contains a live strain, a dried strain, a strain metabolite or an inactivated strain of the Lactobacillus plantarum CCFM1281.
[0011] In one embodiment, the composition is a dairy product for relieving sports fatigue.
[0012] In one embodiment, the dairy product is prepared from Lactobacillus plantarum CCFM1281, Lactobacillus germanica subspecies bulgaricus JMCC0018 and Streptococcus thermophilus JMCC0019; the Lactobacillus germanica subspecies bulgaricus JMCC0018 has been deposited in the China General Microbiological Culture Collection Center of the China Microbiological Culture Collection Administration in 2017, with a deposit number of CGMCC No.14425; the Streptococcus thermophilus JMCC0019 has been deposited in the China General Microbiological Culture Collection Center of the China Microbiological Culture Collection Administration in 2017, with a deposit number of CGMCC No.14426.
[0013] In one embodiment, the dairy product is further supplemented with nutrients such as amino acids and minerals.
[0014] In one embodiment, the formula of the dairy product includes, by mass, 80 parts of raw cow's milk, 5 parts of glucose, 10 parts of soy protein, 13 parts of casein, 10 parts of whey protein, 9 parts of oats, 20 parts of purple sweet potatoes, 0.2 parts of vitamins, 0.05 parts of Lactobacillus delbrueckii subsp. bulgaricus JMCC0018, 0.6 parts of Streptococcus thermophilus JMCC0019, and 1 part of Lactobacillus plantarum CCFM1281.
[0015] In one embodiment, the preparation method of the dairy product is as follows:
[0016] (1) pasteurizing raw milk, adding soy protein powder, casein powder, whey protein powder, and glucose, and stirring well to obtain a mixture A;
[0017] (2) homogenizing the mixture A to obtain a liquid mixture B;
[0018] (3) adding oats, purple sweet potatoes, and vitamins to the liquid mixture B, stirring thoroughly, and sterilizing to obtain a mixture C;
[0019] (4) After the mixture C is cooled, Lactobacillus delbrueckii subsp. bulgaricus JMCC0018, Streptococcus thermophilus JMCC0019, and Lactobacillus plantarum CCFM1281 are added to obtain a liquid mixture D, which is fully stirred and fermented until the pH value is 4.5 to 4.7 to obtain a liquid mixture E, which is stirred to break the emulsion and then cooled to below 4° C. and post-ripened for 11 to 13 hours.
[0020] The third object of the present invention is to provide the use of the Lactobacillus plantarum CCFM1281 in the preparation of medicines for preventing and / or alleviating sports fatigue.
[0021] In one embodiment, the application includes but is not limited to at least one of the following effects:
[0022] (1) Improve the exercise endurance of mammals;
[0023] (2) reduce the increase in serum urea nitrogen levels caused by exercise in mammals;
[0024] (3) Improve the decrease in muscle glycogen levels caused by exercise in mammals;
[0025] (4) improving the decrease in serum glucose levels caused by exercise in mammals;
[0026] (5) Reduce the increase in serum lactate dehydrogenase levels caused by exercise in mammals.
[0027] In one embodiment, the mammal includes but is not limited to humans.
[0028] In one embodiment, the medicine or health product is a variety of solid dosage forms such as capsules, tablets, granules or powders containing Lactobacillus plantarum CCFM1281 and excipients.
[0029] The third object of the present invention is to provide the application of the Lactobacillus plantarum CCFM1281 in the preparation of a health product for relieving sports fatigue.
[0030] In one embodiment, the application includes but is not limited to at least one of the following effects:
[0031] (1) Improve the exercise endurance of mammals;
[0032] (2) reduce the increase in serum urea nitrogen levels caused by exercise in mammals;
[0033] (3) Improve the decrease in muscle glycogen levels caused by exercise in mammals;
[0034] (4) improving the decrease in serum glucose levels caused by exercise in mammals;
[0035] (5) Reduce the increase in serum lactate dehydrogenase levels caused by exercise in mammals.
[0036] In one embodiment, the mammal includes but is not limited to humans.
[0037] In one embodiment, the medicine or health product is a variety of solid dosage forms such as capsules, tablets, granules or powders containing Lactobacillus plantarum CCFM1281 and excipients.
[0038] The invention also provides application of the Lactobacillus plantarum CCFM1281 in preparing fermented food.
[0039] Beneficial effects: the plant lactobacillus CCFM1281 can improve the exhaustion swimming time of fatigue mice and enhance sports endurance; it can reduce the serum urea nitrogen level of fatigue mice and reduce the excessive accumulation of metabolites; it can increase the storage of muscle glycogen in fatigue mice and increase the accumulation of energy substances; it can increase the glucose level in the serum of fatigue mice to maintain the overall energy supply during exercise; it can reduce the level of lactate dehydrogenase in the serum of fatigue mice and reduce sports injuries caused by high-intensity exercise. The plant lactobacillus CCFM1281 can comprehensively relieve sports fatigue by alleviating energy substance consumption, metabolite accumulation, tissue damage and other aspects, and reduce the degree of muscle damage. The present invention also uses plant lactobacillus CCFM1281 for the preparation of dairy products, which has broad application prospects in the field of functional foods.
[0040] Biomaterial Deposit
[0041] Lactobacillus plantarum CCFM1281, classified as Lactiplantibacillus plantarum, was deposited in the Guangdong Provincial Microbiological Culture Collection Center on September 15, 2022. The collection address is 5th Floor, Building 59, No. 100 Xianlie Middle Road, Guangzhou, and the collection number is GDMCC No: 62797. BRIEF DESCRIPTION OF THE DRAWINGS
[0042] Figure 1 is the exhaustive swimming time of mice in different groups;
[0043] Figure 2 is the concentration of serum urea nitrogen in different groups of mice;
[0044] Figure 3 is the muscle glycogen content of mice in different groups;
[0045] Figure 4 is the serum glucose concentration of mice in different groups;
[0046] Figure 5 is the serum lactate dehydrogenase activity of mice in different groups;
[0047] Figure 6 is the serum lactate concentration of mice in different groups;
[0048] Figure 7 is the weight change of mice in different groups;
[0049] Figure 8 is the muscle damage of mice in different groups;
[0050] Among them, all groups were compared with the fatigue group, *P<0.05, **P<0.01. DETAILED DESCRIPTION
[0051] Example 1 Screening of Lactobacillus plantarum CCFM1281 and preparation of bacterial suspension
[0052] (I) Isolation and screening of Lactobacillus
[0053] (1) Fecal samples from a 30-year-old healthy woman were collected and spread on MRS medium, enriched in an anaerobic incubator (N2:CO2:H2=80:10:10) for 12 h, and then the enriched samples were diluted in gradients and spread on MRS solid plates. The gradients were 10 -1 , 10 -2 , 10 -3 , 10 -4 , 10 -5 , 10 -6 , 10 -7 , 10 -8 , were placed in an anaerobic incubator for 48 h.
[0054] (2) Select a plate with an appropriate dilution gradient and use an inoculation loop to pick all colonies that meet the criteria based on the color, size, edge shape, etc. of the colonies and streak them onto the MRS solid plate for purification.
[0055] (3) The above single colony was cultured in liquid MRS culture medium for 24 hours and then Gram-stained, and Gram-positive bacteria were selected for subsequent tests.
[0056] (4) Select 5 Gram-positive bacteria from step (3), perform streak purification again on MRS solid plates, and culture them in an anaerobic incubator for 48 hours to obtain pure culture strains.
[0057] (5) The pure culture strain obtained in step (4) is mixed with sterile glycerol and placed in a strain preservation tube for storage at -80°C.
[0058] (II) Molecular biological identification of Lactobacillus
[0059] (1) The single colony obtained after separation and purification was subjected to 16S rDNA bacterial PCR amplification and identification, and its 16S rDNA sequence was determined as shown in SEQ ID NO.1, and the identification unit was Suzhou Jinweizhi Biotechnology Co., Ltd. Identification result: The strain belongs to the genus Lactobacillus plantarum and is presumed to be Lactobacillus plantarum.
[0060] (2) The identified strain was named Lactobacillus plantarum CCFM1281 and stored at -80°C for future use.
[0061] (III) Preparation of bacterial suspension
[0062] Lactobacillus plantarum CCFM1281 was cultured in MRS medium at 37°C for 12 hours, the culture fluid was collected, the bacterial sludge was collected by centrifugation, washed with physiological saline, and resuspended in skim milk with a concentration of 10% (100 g / L) to prepare a 1.02×10 9 CFU / mL bacterial suspension.
[0063] Example 2: Lactobacillus plantarum CCFM1281 has good tolerance to simulated gastrointestinal fluid
[0064] Lactobacillus plantarum CCFM1281 was inoculated into MRS liquid medium at a volume fraction of 2%, and cultured in a 37°C constant temperature incubator for 12 h. Plate counts of different concentration gradients were performed to obtain a viable bacterial concentration of 1×10 10 CFU / mL of fermentation broth.
[0065] Take 0.5 ml of bacterial solution and centrifuge it at 6000 r / min for 2 min, remove the supernatant, wash the precipitate twice with saline, resuspend the obtained bacterial slurry in 4.5 ml of artificial gastric juice (containing 3 g / L pepsin, pH = 3.0 of saline), mix well and culture in a 37°C constant temperature incubator, take samples at 0 h and 2 h, respectively, use MRS agar medium to cast culture for plate colony count, determine the number of live bacteria and calculate its survival rate, and perform three parallel experiments.
[0066] Take 0.5 ml of bacterial solution and centrifuge at 6000 r / min for 2 min, remove the supernatant, wash the precipitate twice with physiological saline, resuspend the obtained bacterial sludge in 4.5 ml of artificial intestinal fluid (physiological saline containing 1 g / L trypsin, 0.3% bile salt, pH = 8.0), mix well and culture in a 37°C constant temperature incubator, take samples at 0 h, 2 h, and 4 h, pour culture with MRS agar medium to count plate colonies, determine the number of viable bacteria and calculate their survival rate, and repeat the experiment three times.
[0067] The survival rate (%) was calculated as the ratio of the number of viable bacteria in the culture medium at the time of sampling to the number of viable bacteria at 0 h.
[0068] The results are shown in Table 1. Lactobacillus plantarum CCFM1281 has good tolerance in artificial simulated gastrointestinal fluid. The survival rate in the process of tolerating 2 hours of artificial simulated gastric fluid and intestinal fluid reached more than 95%, and the survival rate in the process of tolerating 4 hours of artificial simulated intestinal fluid reached more than 90%, showing good probiotic properties.
[0069] Table 1 Tolerance of Lactobacillus plantarum CCFM1281 in artificial simulated gastrointestinal fluid
[0070]
[0071] Example 3: Animal experiment on the effect of Lactobacillus plantarum CCFM1281 on alleviating sports fatigue
[0072] Preparation of gavage strains: Lactobacillus plantarum CCFM1281, Lactobacillus plantarum FXJWS11M2, and Lactobacillus plantarum ATCC10241 that have been identified and preserved in the bacteria library were taken out, streaked on MRS plates, and cultured at 37°C for 48 hours. Single colonies were picked for two consecutive liquid activations to obtain seed liquid; the seed liquid was centrifuged to obtain bacterial mud, which was redissolved in 10% skim milk, and the number of viable bacteria in the skim milk was calculated using the plate count method. Three gavage reagents were prepared by diluting 10% skim milk at a certain concentration: 1.02×10 9 CFU / mL of Lactobacillus plantarum CCFM1281 in 10% skim milk, with a concentration of 1.02×10 9 CFU / mL of Lactobacillus plantarum FXJWS11M2 in 10% skim milk, concentration was 1.02×10 9 CFU / mL Lactobacillus plantarum ATCC10241 in 10% skim milk. The Lactobacillus plantarum CCFM1281 mentioned above is from Example 1; the Lactobacillus plantarum FXJWS11M2 mentioned above is disclosed in "Mao B, Yin R, Li X, Cui S, Zhang H, Zhao J, Chen W. Comparative Genomic Analysis of Lactiplantibacillus plantarum Isolated from Different Niches. Genes (Basel). 2021 Feb 8; 12 (2): 241. doi: 10.3390 / genes12020241. PMID: 33567604; PMCID: PMC7914981."; Lactobacillus plantarum ATCC10241 was purchased from ATCC.
[0073] Forty healthy male ICR mice were purchased for the experimental animals. The mice were provided with free and sufficient water and feed, and were raised in a specific barrier to maintain appropriate temperature and humidity, with 12 hours of light and darkness. After one week of adaptation, all experimental mice were randomly divided into five groups, namely, the blank group, the fatigue group, the CCFM1281 intervention group, the FXJWS11M2 intervention group, and the ATCC10241 intervention group. The fatigue group and the three intervention groups underwent a six-week weight-bearing swimming modeling experiment, and the weight changes of the mice were recorded every week.
[0074] The mice in the blank group were gavaged daily with 200 μL of 10% skim milk reconstituted with ultrapure water; the mice in the fatigue group were gavaged daily with 200 μL of 10% skim milk reconstituted with ultrapure water; the mice in the CCFM1281 intervention group were gavaged daily with 200 μL of 1.02×10 9 CFU / mL of Lactobacillus plantarum CCFM1281 in 10% skim milk; the FXJWS11M2 intervention group was gavaged daily with 200 μL of 1.02×10 9 CFU / mL of Lactobacillus plantarum FXJWS11M2 in 10% skim milk, and the ATCC10241 intervention group was gavaged daily with 200 μL containing 1.02×10 9 CFU / mL of Lactobacillus plantarum ATCC10241 in 10% skim milk.
[0075] Six weeks after modeling, the exercise endurance of all mice was measured, and the behavioral test was performed using the exhaustive swimming time test: all mice were asked to swim with tail weights, with appropriate wrapping tightness, and the total weight was 5% of their body weight, and they were placed alone in a swimming box with a water depth of 50 cm and a water temperature of 25℃±1℃. The timing started from the moment the mouse entered the water tank. When the mouse swam under the water surface for three consecutive times, each time for more than 7s, it was considered to be exhausted, and the exhaustive swimming time was recorded. The results are shown in Table 2.
[0076] Table 2 Animal experimental behavioral indicators
[0077] Group Exhaustive swimming time (s) Blank group 828.333±295.663 Fatigue group 315±96.281 CCFM1281 intervention group 971.833±387.685 FXJWS11M2 intervention group 415.143±188.606 ATCC10241 intervention group 438.75±158.784
[0078] Note: All values are expressed as Mean ± SD
[0079] The results showed that compared with the blank group, the weighted swimming modeling experiment significantly reduced the exhaustive swimming time of mice in the fatigue group; compared with the fatigue group, the Lactobacillus plantarum CCFM1281 intervention group was able to significantly increase the exhaustive swimming time. This shows that exercise fatigue can lead to a significant decrease in exercise endurance, and Lactobacillus plantarum CCFM1281 can significantly improve the anti-fatigue ability and exercise endurance of mice; while FXJWS11M2 and ATCC10241, which are also Lactobacillus plantarum, did not significantly improve the exhaustive swimming time and had no significant effect on the exercise endurance of mice.
[0080] After testing the exercise endurance of all mice, all mice were made to swim without weight in a water tank the next day. After swimming for 30 minutes, the eyeballs were immediately removed to collect blood, and the mice were killed and dissected by cervical dislocation. A whole blood sample was taken and frozen at -80°C; the remaining blood samples were centrifuged at 3500r / min for 15 minutes, the supernatant was taken, and frozen at -80°C for serum index analysis; tissue samples (muscle, liver) were packaged, quickly frozen in liquid nitrogen, and transferred to -80°C for freezing for tissue index analysis; the right leg gastrocnemius muscle was stored in 4% paraformaldehyde, kept away from light, and used for section analysis.
[0081] Example 4: Animal experiment on the effect of Lactobacillus plantarum CCFM1281 on alleviating sports fatigue: analysis of serum lactic acid and serum urea nitrogen content
[0082] The establishment of the animal model was the same as in Example 3, and the serum urea nitrogen and serum lactic acid levels in the serum samples of all mice after 30 minutes of weightless swimming were detected. The determination of serum urea nitrogen and serum lactic acid was carried out according to the kit method.
[0083] As shown in Table 3, compared with the blank group, the weighted swimming modeling experiment significantly increased the serum urea nitrogen of the mice in the fatigue group; compared with the fatigue group, the serum urea nitrogen of the Lactobacillus plantarum CCFM1281 intervention group was significantly reduced. This shows that exercise fatigue can lead to excessive accumulation of serum urea nitrogen, and Lactobacillus plantarum CCFM1281 can effectively counteract the disorder of ammonia metabolism caused by exercise fatigue, thereby effectively alleviating exercise fatigue; compared with the fatigue group, the Lactobacillus plantarum FXJWS11M2 intervention group and Lactobacillus plantarum ATCC10241 had almost no effect on the serum urea nitrogen content.
[0084] As for serum lactate levels, although there was a trend of reduced serum lactate in mice in the CCFM1281 intervention group, there was no significant difference among the groups.
[0085] Table 3 Analysis of blood lactate and blood urea nitrogen in animal experiments
[0086] Group Serum lactate (mmol / L) Serum urea nitrogen (mmol / L) Blank group 10.258±1.068 15.296±1.084 Fatigue group 10.521±1.637 18.396±2.965 CCFM1281 intervention group 8.74±1.877 14.387±1.391 FXJWS11M2 intervention group 10.512±3.271 21.777±3.177 ATCC10241 intervention group 11.637±2.44 18.371±1.953
[0087] Example 5: Animal experiment on the effect of Lactobacillus plantarum CCFM1281 on alleviating sports fatigue: analysis of glycogen content in muscle tissue
[0088] The establishment of the animal model was the same as in Example 3. The glycogen levels in the muscle tissue samples of all mice were detected after 30 minutes of weight-free swimming. The determination of muscle glycogen levels was performed according to the kit method.
[0089] As shown in Table 4, compared with the blank group, the weighted swimming modeling experiment significantly reduced the muscle glycogen level of mice in the fatigue group; compared with the fatigue group, the muscle glycogen level of mice in the Lactobacillus plantarum CCFM1281 intervention group was significantly increased. This shows that the anaerobic metabolism of muscles during exercise fatigue will lead to excessive consumption of muscle glycogen, and the accumulation amount is greatly reduced; while Lactobacillus plantarum CCFM1281 can effectively increase the energy reserve in the muscles of mice while maintaining the same exercise intensity, thereby effectively alleviating exercise fatigue; while FXJWS11M2 and ATCC10241, which are also Lactobacillus plantarum, have no significant effect on the characterization of glycogen content in peripheral muscle tissue.
[0090] Table 4 Muscle glycogen indexes in muscle tissue of animal experiments
[0091] Group Muscle glycogen (mg / g) Blank group 0.858±0.125 Fatigue group 0.656±0.091 CCFM1281 intervention group 0.909±0.212 FXJWS11M2 intervention group 0.704±0.184 ATCC10241 intervention group 0.649±0.071
[0092] Example 6: Animal experiment on the effect of Lactobacillus plantarum CCFM1281 on alleviating sports fatigue: analysis of serum lactate dehydrogenase activity
[0093] The establishment of the animal model was the same as in Example 3. The lactate dehydrogenase activity in the serum of all mice was detected after swimming without weight for 30 minutes. The determination of lactate dehydrogenase activity in the serum was carried out according to the kit method.
[0094] As shown in Table 5, compared with the blank group, the weighted swimming modeling experiment significantly increased the lactate dehydrogenase activity of the fatigue group mice; compared with the fatigue group, the lactate dehydrogenase activity of the Lactobacillus plantarum CCFM1281 intervention group was significantly reduced. This shows that exercise fatigue can cause serious damage to the muscle tissue of mice, resulting in excessive lactate dehydrogenase entering the blood; and Lactobacillus plantarum CCFM1281 can reduce muscle damage to mice during exercise, thereby effectively alleviating exercise fatigue. However, Lactobacillus plantarum FXJWS11M2 and Lactobacillus plantarum ATCC10241 had no significant effect on the serum phenotypic indicators caused by muscle tissue damage caused by exercise fatigue.
[0095] Table 5 Serum lactate dehydrogenase indexes in animal experiments
[0096] Group Lactate dehydrogenase (U / L) Blank group 2948.646±189.671 Fatigue group 3270.588±259.494 CCFM1281 intervention group 2433.551±395.318 FXJWS11M2 intervention group 2801.12±479.504 ATCC10241 intervention group 3074.254±454.407
[0097] Example 7: Animal experiment on the effect of Lactobacillus plantarum CCFM1281 on alleviating sports fatigue: analysis of serum glucose levels
[0098] The establishment of the animal model was the same as in Example 3. The glucose level in the serum of all mice was detected after 30 minutes of weight-free swimming. The determination of the glucose level in the serum was performed according to the kit method.
[0099] As shown in Table 6, compared with the blank group, the weighted swimming modeling experiment caused a downward trend in the serum glucose level of the fatigue group mice, but it was not significant; compared with the fatigue group, the glucose level of the Lactobacillus plantarum CCFM1281 intervention group was significantly increased. This shows that exercise fatigue will reduce the supply of glucose during exercise in mice, and the overall energy supply will be reduced; while Lactobacillus plantarum CCFM1281 can enable the muscle tissue of mice to obtain sufficient glucose during exercise, reduce the loss of liver glycogen and muscle glycogen, and thus effectively relieve exercise fatigue. However, FXJWS11M2 and ATCC10241, which are also Lactobacillus plantarum, have no significant effect on serum glucose levels.
[0100] Table 6 Serum glucose indexes in animal experiments
[0101] Group Glucose (mmol / L) Blank group 3.955±0.975 Fatigue group 2.978±0.98 CCFM1281 intervention group 4.677±0.597 FXJWS11M2 intervention group 4.157±0.928 ATCC10241 intervention group 3.798±0.448
[0102] Example 8: Animal experiment on the effect of Lactobacillus plantarum CCFM1281 on alleviating sports fatigue: analysis of weight changes in mice
[0103] The animal model was established in the same manner as in Example 3, and the weight changes of mice were detected every week. Figure 7 As shown in the figure, compared with the blank group, the weight-bearing swimming modeling experiment slowed down the weight gain rate of mice in the fatigue group, but had no adverse effects on the health of the mice; the weight changes of mice in the Lactobacillus plantarum CCFM1281 intervention group, the Lactobacillus plantarum FXJWS11M2 intervention group, and the Lactobacillus plantarum ATCC10241 intervention group were between the fatigue group and the blank group, with no significant difference. This shows that exercise fatigue can make mice thinner and slow down the weight gain during growth and development; while Lactobacillus plantarum has little effect on the overall weight change of mice, and Lactobacillus plantarum CCFM1281 cannot reverse the weight changes caused by exercise fatigue.
[0104] Example 9: Animal experiment on the effect of Lactobacillus plantarum CCFM1281 on alleviating sports fatigue: muscle tissue pathological section analysis
[0105] According to Example 3 of the present invention, in order to evaluate whether Lactobacillus plantarum CCFM1281 has adverse pathological effects on muscle tissue, gastrocnemius muscle in muscle tissue samples was taken for pathological section analysis.
[0106] like Figure 8As shown in the figure, the pathological manifestations of gastrocnemius muscle of mice in the blank group were that the size of muscle cells was slightly different and arranged in polygonal shape. Each muscle cell had several myocyte nuclei located under the sarcolemma, and there was no obvious inflammatory cell infiltration in the whole section; the pathological manifestations of gastrocnemius muscle of mice in the fatigue group were that some muscle cells were whitish and necrotic, with obvious swelling and atrophy, large and multiple cracks appeared between cells, and there was obvious and serious inflammatory cell infiltration; compared with the fatigue group, the pathological manifestations of gastrocnemius muscle of mice in the Lactobacillus plantarum CCFM1281 intervention group were that the muscles were arranged relatively tightly, but there were still large gaps, and a small number of muscle cells showed whitish cracks, and the histopathological structure was close to that of gastrocnemius muscle of mice in the blank group. This shows that Lactobacillus plantarum CCFM1281 can effectively alleviate the damage to muscles caused by exercise fatigue.
[0107] Example 10: Use of Lactobacillus plantarum CCFM1281 in the preparation of dairy products for relieving sports fatigue
[0108] Formula: 80 parts of raw milk, 5 parts of glucose, 10 parts of soy protein, 13 parts of casein, 10 parts of whey protein, 9 parts of oats, 20 parts of purple sweet potato, 0.2 parts of vitamins, 0.05 parts of Lactobacillus delbrueckii subsp. bulgaricus JMCC0018, 0.6 parts of Streptococcus thermophilus JMCC0019, 1 part of Lactobacillus plantarum CCFM1281, the concentration of each strain is 10 11 CFU / g; among them, Lactobacillus delbrueckii subspecies bulgaricus JMCC0018 has been deposited in the China General Microbiological Culture Collection Center of China Microorganism Culture Collection Administration in 2017, with the deposit number: CGMCC No.14425; Streptococcus thermophilus JMCC0019 has been deposited in the China General Microbiological Culture Collection Center of China Microorganism Culture Collection Administration in 2017, with the deposit number: CGMCCNo.14426.
[0109] Production process:
[0110] (1) Raw milk is pasteurized at a temperature of 89.5-90.5° C. for 14-16 seconds, and after cooling to a temperature of 40-45° C., soy protein powder, casein powder, whey protein powder, and glucose are added respectively, and the mixture is stirred thoroughly to obtain a mixture A;
[0111] (2) homogenizing the mixture A at a homogenization temperature of 60 to 65° C. and a homogenization pressure of 16 to 20 MPa to obtain a liquid mixture B;
[0112] (3) adding oats, purple sweet potatoes and vitamins to mixture B and stirring thoroughly, and then sterilizing at a temperature of 94.5 to 95.5° C. for a time of 298 to 302 seconds to obtain mixture C;
[0113] (4) After cooling the mixture C to 36-38° C., activated Lactobacillus delbrueckii subspecies bulgaricus JMCC0018, Streptococcus thermophilus JMCC0019, and Lactobacillus plantarum CCFM1281 were added to obtain a mixture D, which was fully stirred and fermented until the pH value was 4.5-4.7, and then stopped to obtain a mixture E. After stirring and breaking the emulsion, the mixture was cooled to below 4° C. and post-ripened for 11-13 hours. The effect of the dairy product was verified according to the method of Examples 3-9, and the results showed that the obtained dairy product had the effect of relieving sports fatigue.
[0114] Although the present invention has been disclosed as above in the form of a preferred embodiment, it is not intended to limit the present invention. Anyone familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be based on the definition of the claims.
Claims
1. Lactobacillus plantarum ( Lactiplantibacillus plantarum )CCFM1281 was deposited in Guangdong Provincial Microbiological Culture Collection Center on September 15, 2022, with the deposit number GDMCC No: 62797.
2. A composition containing the live strain of Lactobacillus plantarum CCFM1281 according to claim 1.
3. The composition according to claim 2, It is characterized in that The number of Lactobacillus plantarum CCFM1281 is ≥1×10 9 CFU / mL or ≥1×10 9 CFU / g.
4. The composition according to claim 2 or 3, It is characterized in that The composition is a microbial preparation.
5. The composition according to claim 2 or 3, It is characterized in that The composition is a functional food.
6. The composition according to claim 2 or 3, It is characterized in that The invention relates to a dairy product containing Lactobacillus plantarum CCFM1281, Lactobacillus germanica subspecies bulgaricus JMCC0018 and Streptococcus thermophilus JMCC0019; the Lactobacillus germanica subspecies bulgaricus JMCC0018 has been deposited in the China General Microbiological Culture Collection Center in 2017, with a deposit number of CGMCC No. 14425; the Streptococcus thermophilus JMCC0019 has been deposited in the China General Microbiological Culture Collection Center in 2017, with a deposit number of CGMCC No. 14426.
7. Use of the Lactobacillus plantarum CCFM1281 according to claim 1 in the preparation of medicines for preventing and / or alleviating sports fatigue.
8. The use according to claim 7, It is characterized in that The medicine is a solid preparation containing Lactobacillus plantarum CCFM1281 and auxiliary materials.
9. The use according to claim 8, It is characterized in that The solid preparation is a capsule, a tablet, a granule or a powder.
10. Use of the Lactobacillus plantarum CCFM1281 according to claim 1 in preparing a health product for relieving sports fatigue.
11. The use according to claim 10, It is characterized in that The health product is a solid preparation containing plant lactobacillus CCFM1281 and auxiliary materials.
12. The use according to claim 11, It is characterized in that The solid preparation is a capsule, a tablet, a granule or a powder.
13. Use of the plant lactobacillus CCFM1281 according to claim 1 in preparing fermented food.
